Advanced Biomed Inc. (NASDAQ:ADVB) Short Interest Update

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a significant growth in short interest in June. As of June 30th, there was short interest totaling 15,397 shares, a growth of 73.5% from the June 15th total of 8,876 shares. Approximately 1.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 14,727 shares, the days-to-cover ratio is presently 1.0 days.

Advanced Biomed Price Performance

Shares of ADVB stock opened at $5.25 on Friday. Advanced Biomed has a twelve month low of $3.61 and a twelve month high of $16.13. The stock’s fifty day moving average price is $4.65. The company has a market cap of $8.66 million, a price-to-earnings ratio of 1.09 and a beta of 0.52.

Advanced Biomed (NASDAQ:ADVB) last posted its earnings results on Saturday, May 16th. The company reported ($0.38) EPS for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Advanced Biomed from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.